A medical device having a polymer-free outer surface layer comprising a crystalline drug selected from the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and rapamycin. The device may be produced by a method comprising the steps of providing a medical device; applying
A medical device having a polymer-free outer surface layer comprising a crystalline drug selected from the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and rapamycin. The device may be produced by a method comprising the steps of providing a medical device; applying a solution of the drug to said portion of the outer surface to form a coating of amorphous drug; and vapor annealing the drug with a solvent vapor to form crystalline drug; wherein a seed layer of a crystalline form of said drug having a maximum particle size of about 10 μm or less is applied to at least said portion of the outer surface of the device before or after applying the drug solution, but before vapor annealing the amorphous coating.
대표청구항▼
1. A method of forming a coating comprising a drug on at least a portion of an outer surface of a medical device, the drug being a member of the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and rapamycin, the method comprising the steps of: providing a medical device
1. A method of forming a coating comprising a drug on at least a portion of an outer surface of a medical device, the drug being a member of the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and rapamycin, the method comprising the steps of: providing a medical device;applying a solution of the drug to said portion of the outer surface to form a coating of amorphous drug;providing crystals of the drug;grinding the crystals of the drug to form microcrystals of the drug having a maximum size of about 10 μm or less;applying the microcrystals of the drug to at least said portion of the outer surface of the device; andvapor annealing the coating of amorphous drug with a solvent vapor to form crystalline drug; the solvent selected from the group consisting of alcohols, acetonitrile, ethers, ketones solvents, halogenated solvents, aliphatic hydrocarbons, aromatic hydrocarbons, and ester solvents,wherein the microcrystals of the drug are applied before or after applying the drug solution, but prior to any vapor annealing of the coating of amorphous coating. 2. A method as in claim 1 wherein the drug is everolimus. 3. A method as in claim 1 wherein the microcrystals of the drug form a seed layer on the portion of the outer surface of the device having a coat weight of less than 0.05 μg/mm2. 4. A method as in claim 1 wherein the microcrystals are seed layer is applied from suspension in a liquid vehicle. 5. A method as in claim 1 wherein the solvent vapor is generated by vaporization of a liquid solvent composition in a chamber and the liquid solvent composition further comprises a non-volatile solute. 6. A method as in claim 1 wherein the medical device is a stent. 7. A method as in claim 6 wherein the device is a metal stent having grooves or depressions thereon, the drug solution is free of any excipient, and the drug solution is applied to said grooves or depressions on the outer surface of the stent. 8. A method of forming a coating comprising a drug on at least a portion of an outer surface of a medical device, the drug being a member of the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and rapamycin, the method comprising the steps of: applying a solution of the drug to said portion of the outer surface to form a coating of amorphous drug;providing crystals of the drug;preparing a microcrystalline form of said drug by breaking the crystals of the drug into microcrystals having a maximum particle size of about 10 μm or less;applying the microcrystals to at least said portion of the outer surface of the device; andsubsequently vapor annealing the amorphous coating with a solvent vapor to form crystalline drug; the solvent vapor consisting of a vapor of a solvent selected from the group consisting of alcohols, acetonitrile (ACN); ethers, ketones solvents, halogenated solvents, aliphatic hydrocarbons, aromatic hydrocarbons, and ester solvents,wherein the microcrystals are applied to at least said portion of the outer surface of the device before or after applying the drug-solution, but prior to any vapor annealing of the amorphous coating. 9. A method as in claim 8 wherein the medical device is a catheter balloon. 10. A method as in claim 9 wherein the drug is everolimus. 11. A method as in claim 8 wherein the medical device is a stent. 12. A method as in claim 11 wherein the drug is everolimus. 13. The method of claim 6 wherein the medical device is a catheter balloon. 14. The method of claim 8 wherein the step of preparing a microcrystalline form of said drug comprises the step of grinding the crystallized drug to a desired size range. 15. The method of claim 8 wherein during the step of preparing a microcrystalline form of said drug, the drug crystals are subjected to sonication in a slurry. 16. A method of forming a coating comprising a drug on at least a portion of an outer surface of a medical device, the drug being a member of the group consisting of everolimus, tacrolimus, sirolimus, zotarolimus, biolimus, and rapamycin, the method comprising the steps of: providing a medical device;applying a solution of the drug to said portion of the outer surface to form a coating of amorphous drug;providing seed crystals of the drug, the seed crystals having a major dimension ranging from about 10 nm to about 20 μm;disposing the seed crystals of the drug on at least said portion of the outer surface of the device;vapor annealing the drug with a solvent vapor to form crystalline drug; the solvent selected from the group consisting of alcohols, acetonitrile, ethers, ketones solvents, halogenated solvents, aliphatic hydrocarbons, aromatic hydrocarbons, and ester solvents,wherein the seed crystals of the drug are applied to at least said portion of the outer surface of the device before or after applying the drug solution, but prior to subjecting the medical device to any vapor annealing.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (302)
Morris, Grayson; Atladottir, Svava Maria; Pienknagura, Carla, Abluminal stent coating apparatus and method using a brush assembly.
Herweck, Steve A.; Martakos, Paul; Moodie, Geoffrey; Labrecque, Roger; Karwoski, Theodore; Carlton, Trevor, Application of a therapeutic substance to a tissue location using an expandable medical device.
Wolinsky Harvey (New York NY) King Spencer L. (Atlanta GA) Barbere Michael D. (Dunstable MA), Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen.
Bacher Peter (Nurnberg DEX) Walenga Jeanine M. (Lombard IL), Catheter and method for the prevention and/or treatment of stenotic processes of vessels and cavities.
Lindall Arnold W. (1150 Nordic Ave. North ; P.O. Box 187 Stillwater MN 55082), Catheter system for controllably releasing a therapeutic agent at a remote tissue site.
Bates, Brian L.; Ragheb, Anthony O.; Stewart, IV, Joseph M.; Bourdeau, William J.; Choules, Brian D.; Purdy, James D.; Fearnot, Neal E., Coated implantable medical device.
Fearnot Neal E. (West Lafayette IN) Kozma Thomas G. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees William D. (West Lafayette IN), Coated implantable medical device.
Bates, Brian L.; Boatman, Scott E.; Burton, David G.; Hoffa, Michael C.; Schaeffer, Darin G.; Sturgeon, Jason S.; Ragheb, Anthony O., Coated medical device.
Ragheb, Anthony O.; Bates, Brian L.; Boatman, Scott E.; Burton, David G.; Hoffa, Michael C.; Schaeffer, Darin G.; Sturgeon, Jason S., Coated medical device.
Brem Henry (Lutherville MD) Langer Robert S. (Newton MA) Domb Abraham J. (Efrat ILX), Controlled local delivery of chemotherapeutic agents for treating solid tumors.
Brem Henry (Lutherville MD) Langer Robert S. (Newton MA) Domb Abraham J. (Efrat ILX), Controlled local delivery of chemotherapeutic agents for treating solid tumors.
Anderson David C. (Seattle WA) Morgan ; Jr. A. Charles (Edmonds WA) Abrams Paul G. (Seattle WA) Fritzberg Alan R. (Edmonds WA) Nichols Everett J. (Seattle WA), Covalently-linked complexes and methods for enhanced cytotoxicity and imaging.
Crocker Michael (Mission Viejo CA) Henson Michael (Pleasanton CA) Chum Muny (Santa Ana CA), Delivery and balloon dilatation catheter and method of using.
Crocker Michael D. (Mission Viejo CA) Henson Michael R. (Pleasonton CA) Chum Muny (Santa Ana CA), Drug delivery and dilatation catheter having a reinforced perfusion lumen.
Shapland James E. (Shoreview MN) Knudson Mark B. (Shoreview MN) Shimada Jin (Falcon Heights MN) Hildebrand Keith R. (Houlton WI), Drug delivery apparatus and method.
Amundson Rodney R. (Lindstrom MN) Hull Vincent W. (Ham Lake MN) Dror Michael (Edina MN) Schwartz Robert S. (Rochester MN), Drug delivery balloon catheter with line of weakness.
Harrison Kent D. (Brooklyn Park MN) Hendrickson Gary L. (Big Lake MN) Holman Thomas J. (Minneapolis MN) Lafontaine Daniel M. (Plymouth MN) Miller Matthew J. (White Bear Lake MN) Robinson David B. (Ch, Drug delivery catheter with manifold.
Nicholas Peter M. (South Dartmouth MA) Sahatjian Ronald A. (Lexington MA) Barry James J. (Marlborough MA), Drug treatment of diseased sites deep within the body.
Herweck, Steve A.; Gingras, Peter H.; Martakos, Paul; Karwoski, Theodore, Expandable fluoropolymer device for delivery of therapeutic agents and method of making.
Eversull, Christian Scott; Mourlas, Nicholas J.; Leeflang, Stephen Arie; Nayak, Asha Shrinivas; Miller, David John, Expandable guide sheath and apparatus and methods using such sheaths.
Abele John E. (Concord MA) Heath Kevin R. (Providence RI) Landman Mark S. (Sharon MA) McLaughlin Paul D. (Scituate MA), Guidewire for crossing occlusions in blood vessels.
Richard,Robert E.; Strickler,Frederick H., Implantable or insertable medical devices containing graft copolymer for controlled delivery of therapeutic agents.
Schwartz Robert S. (Rochester MN) Bresnahan John (Rochester MN) Bergman Rebecca M. (North Oaks MN) Coury Arthur J. (St. Paul MN) Lindell Elaine (Blaine MN) Hull Vincent W. (Fridley MN) Dror Michael (, Intravascular radially expandable stent.
Brown ; III Charles L. ; Crawford Neville,GBX ; Freear Steven,GBX, Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues.
Shyam Sundar Sarkar, METHOD AND APPARATUS FOR PROCESSING MARKUP LANGUAGE SPECIFICATIONS FOR DATA AND METADATA USED INSIDE MULTIPLE RELATED INTERNET DOCUMENTS TO NAVIGATE, QUERY AND MANIPULATE INFORMATION FROM A PLURALITY.
Williams, Simon F.; Martin, David P.; Gerngross, Tillman; Horowitz, Daniel M., Medical device containing polyhydroxyalkanoate treated with oxidizing agent to remove endotoxin.
Norton William J. (Berkeley Heights NJ), Medical tubing having exterior hydrophilic coating for microbiocide absorption therein and method for using same.
Klein Enrique J. (Los Altos CA) Bajor Jordan (Palo Alto CA) Alba Paul (San Jose CA) Kaplan Aaron V. (Los Altos CA), Method and apparatus for providing external perfusion lumens on balloon catheters.
Shapland James E. (Shoreview MN) Hildebrandt Keith R. (Houlton WI) Knudson Mark B. (Shoreview MN), Method for iontophoretically delivering drug adjacent to a heart.
Amundson Rodney R. (Lindstrom MN) Hull Vincent W. (Ham Lake MN) Dror Michael (Edina MN) Schwartz Robert S. (Rochester MN), Method for making a drug delivery balloon catheter.
Schwartz Abraham (Durham NC) Graper Jane (Durham NC) Williams Joel (Cary NC), Method of applying a hydrophilic coating to a polymeric substrate and articles prepared thereby.
Ferguson Robert D. G. (Memphis TN) Tartaglino Sandra G. (Canton MA), Method of delivering a therapeutic agent or diagnostic device using a micro occlusion balloon catheter.
Machold Timothy R. (Moss Beach CA) Robinson Janine C. (Half Moon Bay CA) Michaels Mary B. (Sunnyvale CA) Sirhan Motasim M. (Sunnyvale CA), Method of delivery therapeutic or diagnostic liquid into tissue surrounding a body lumen.
Anderson Jere R. (Newburyport MA) Jandris Louis J. (Georgetown MA) Barbere Michael D. (Dunstable MA) Murphy Richard T. (Dracut MA 4), Method of making a distensible dilatation balloon using a block copolymer.
Fefeu Michel A. (Magny les Hameaux FRX) Perrin Grard (Chatenois les Forges FRX), Method of manufacturing a hollow shaft with internal swellings of revolution and shaft obtained by this method.
Kresse Mayk (Berlin DEX) Lawaczeck Rudiger (Berlin DEX) Pfefferer Detlef (Berlin DEX), Nanocrystalline magnetic iron oxide particles-method for preparation and use in medical diagnostics and therapy.
Lesniak, Christoph; Schiestel, Thomas; Schmidt, Helmut; Jordan, Andreas, Nanoscale particles having an iron oxide-containing core enveloped by at least two shells.
Raad Isaam (Houston TX) Sherertz Robert (Winston-Salem NC), Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and.
Lesniak Christoph,DEX ; Schiestel Thomas,DEX ; Nass Rudiger,DEX ; Schmidt Helmut,DEX, Process for preparing agglomerate-free nanoscalar iron oxide particles with a hydrolysis resistant coating.
Shapland James E. (Shoreview MN) Knudson Mark B. (Shoreview MN) Shimada Jin (Falcon Heights MN) Racchini Joel R. (Edina MN), Simultaneous angioplasty and phoretic drug delivery.
Scott Neal A. (Atlanta GA) Hanson Stephen R. (Stone Mountain GA) King ; III Spencer B. (Atlanta GA) Harker Laurence A. (Atlanta GA), Stent sheath for local drug delivery.
Pinaki Ray ; Vinayak D. Bhat ; Daryush Mirzaee, Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway.
Ray,Pinaki; Bhat,Vinayak D.; Mirzaee,Daryush, Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway.
Wu, Steven Z.; Harish, Sameer; Sanders-Millare, Deborra; Guruwaiya, Judy A.; Mirzaee, Daryush; Hossainy, Syed; Chen, Charlene, Surface features of an implantable medical device.
Barnikol,Wolfgang; Burkhard,Oswald; P철tzschke,Harald; Domack,Ulrike; Dinkelmann,Stephanie; Fiedler,Bernd; Manz,Birgit, Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof.
Flaherty, J. Christopher; Makower, Joshua; Evard, Philip C.; MacAulay, Patrick E.; Whitt, Jason B.; Colloton, Robert C.; Macfarlane, K. Angela, Systems and methods for delivering drugs to selected locations within the body.
Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
Brisken Axel F. ; McKenzie John R. ; Zuk Robert F. ; Nassi Menahem ; Cowan Mark W. ; Corl Paul D., Therapeutic ultrasonic catheter for delivering a uniform energy dose.
Fearnot Neal E. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees ; III William D. (West Lafayette IN), Thrombolytic treated intravascular medical device.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.